S100A8, MMP-8 and MPO are involved in lung pathology [5,18,29,30,51] as consequences of lung tissue degradation in tuberculosis [18,29,30], emphysema [52], COVID-19 [53] or COPD [54]. Here, S100A8 is linked to pulmonary emphysema.